drugset / Trial / NCT01126424

A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability

NCT01126424

Phase 4 Completed 26 enrolled Astellas Pharma Inc
RandomizedCrossoverQuadruple-blind

Summary

The purpose is to compare solifenacin and oxybutynin with an inactive tablet and assess any potential effects on mental ability.

Timeline

Start
2010-04
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxybutynin Small molecule 5 mg
Subject Solifenacin Small molecule 5 mg

Indications

No indication recorded.